The Product Information File, commonly referred to as the PIF, is one of the cornerstone documents required to demonstrate the safety and regulatory compliance of cosmetic products in the European Union. Under the provisions of the Regulation (EC) No 1223/2009, every cosmetic product placed on the market must be supported by a complete and up […]
Safety Data Sheets, commonly referred to as SDSs, are essential regulatory documents for communicating information on chemical hazards, safe handling, exposure controls and emergency measures. An accurate and up to date SDS supports regulatory compliance, occupational safety and effective chemical risk management throughout the supply chain. The regulatory requirements governing Safety Data Sheets vary across […]
Il team di ToxHub è lieto di condividere la propria partecipazione al 23° Congresso Nazionale SITOX tenutosi dall’8 al 10 giugno 2026 presso l’Hotel Savoia Regency di Bologna. Da oltre cinquant’anni, SITOX rappresenta uno dei principali punti di riferimento per la comunità tossicologica italiana, riunendo ricercatori, professionisti, aziende, istituzioni e autorità regolatorie per discutere le […]
Il team di ToxHub è lieto di annunciare la propria partecipazione al 65° Simposio AFI, che si terrà dal 10 al 12 giugno 2026 presso il Palacongressi di Rimini. L’edizione di quest’anno, intitolata “L’Industria della Salute nel tempo dell’Intelligenza Artificiale”, rappresenta uno degli appuntamenti più rilevanti per la filiera farmaceutica italiana, offrendo un’importante occasione di […]
ToxHub is pleased to announce that Chiara Gazerro will participate as an invited speaker at the 2nd EuroPotent 360 Summit taking place in Milan on 20 to 22 May 2026. This international event brings together experts from across the pharmaceutical industry to discuss the scientific, toxicological, and regulatory challenges associated with Highly Potent Active Pharmaceutical […]
The control and qualification of impurities remain among the most critical aspects in the development and lifecycle management of pharmaceutical products. However, the recently published reflection paper from the European Medicines Agency signals an important evolution in how non-genotoxic impurities should be assessed, justified, and managed during pharmaceutical development. Until recently, qualification of non-genotoxic impurities […]
ToxHub is pleased to announce that Chiara Gazerro will participate as an invited speaker at the MaxPotent Pharma Summit 2026 taking place in Milan on 6 to 7 May 2026. This international event brings together experts from across the pharmaceutical industry to address scientific and regulatory challenges associated with highly potent active pharmaceutical ingredients, commonly […]
The newly released draft of the ICH Q3E guideline represents a significant milestone in the harmonisation of global expectations for the assessment and control of extractables and leachables (E&L) in pharmaceutical products. Building on the foundations laid by ICH Q3A, Q3B, Q3C, Q3D, and M7, it distinguishes itself by adopting a more integrated and systematic […]
Glyphosate has been undes scrutiny since many years. Discovered in 1970 by a scientist at Monsanto, and since commercialization in 1974, its use has grown to dominate the herbicide market. Over the years, several epidemilogical studies were published, linking the chemical to adverse human health outcomes. Nine epidemiological studies were centered on neurodegenerative outcomes (two […]
The Environmental Risk Assessment (ERA) play a key role in regulatory submissions for medicines in the European Union. The European Medicines Agency (EMA) requires a clear, evidence-based process to assess the potential environmental impact of active pharmaceutical ingredients (APIs) that enter the environment through patient use. With the updated EMA guideline (EMEA/CHMP/SWP/4447/00 Rev. 1 – EMA […]










